COPT Defense Properties (NYSE:CDP) Reaches New 1-Year High – Here’s Why
by Renee Jackson · The Cerbat GemCOPT Defense Properties (NYSE:CDP – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $31.51 and last traded at $31.4150, with a volume of 19305 shares trading hands. The stock had previously closed at $30.74.
Key Headlines Impacting COPT Defense Properties
Here are the key news stories impacting COPT Defense Properties this week:
- Positive Sentiment: Q4 results beat consensus — GAAP EPS/FFO of $0.70 topped estimates (~$0.68) and revenue of $197.4M beat forecasts; revenue was up 7.6% year-over-year, showing organic growth and margin strength. MarketBeat Earnings Release
- Positive Sentiment: Company set 2026 FFO-per-share guidance of $2.71–$2.79 (Nareit and adjusted), materially above prior consensus; management also provided FY 2026 diluted EPS and 1Q guidance, improving forward visibility. This higher FFO guide is the main driver of the rally. Business Wire — 2026 Guidance
- Positive Sentiment: Material lease wins and financing activity — executed a full-building 148,000 sq ft lease with a top-10 U.S. defense contractor, pushing the development pipeline to ~86% leased and management closed financings that pre-fund development — supports near-term cash flow and growth. Business Wire — Lease Announcement
- Positive Sentiment: Management commentary and supplemental materials (slide deck, call) emphasize outperformance in FFO, leasing, and capital deployment; slides and presentation improve transparency for investors. Seeking Alpha — Slide Deck & Presentation
- Neutral Sentiment: Q1 guidance is essentially in-line with street expectations (range provided that matches consensus), so near-term upside from guidance is limited; the bigger driver is the FFO outlook. Business Wire — 1Q Guidance
Analysts Set New Price Targets
CDP has been the subject of several research reports. Weiss Ratings restated a “buy (b-)” rating on shares of COPT Defense Properties in a research report on Wednesday, January 21st. Evercore reissued an “outperform” rating on shares of COPT Defense Properties in a research report on Friday. Truist Financial boosted their target price on COPT Defense Properties from $30.00 to $31.00 and gave the company a “hold” rating in a research note on Monday, December 15th. Jefferies Financial Group increased their price target on COPT Defense Properties from $33.00 to $34.00 and gave the stock a “buy” rating in a research note on Tuesday, January 27th. Finally, Wells Fargo & Company lifted their target price on shares of COPT Defense Properties from $30.00 to $33.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Six research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $33.00.
Get Our Latest Stock Report on CDP
COPT Defense Properties Trading Up 1.4%
The company has a debt-to-equity ratio of 1.57, a current ratio of 2.34 and a quick ratio of 2.34. The stock has a market cap of $3.67 billion, a P/E ratio of 24.04 and a beta of 0.86. The firm’s fifty day moving average price is $29.53 and its two-hundred day moving average price is $29.08.
COPT Defense Properties (NYSE:CDP – Get Free Report) last announced its earnings results on Thursday, February 5th. The company reported $0.70 earnings per share for the quarter, topping analysts’ consensus estimates of $0.68 by $0.02. The business had revenue of $197.36 million for the quarter, compared to analyst estimates of $188.79 million. COPT Defense Properties had a return on equity of 9.85% and a net margin of 19.94%.The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.65 EPS. COPT Defense Properties has set its FY 2026 guidance at 2.710-2.790 EPS and its Q1 2026 guidance at 0.670-0.690 EPS. As a group, equities research analysts forecast that COPT Defense Properties will post 2.67 EPS for the current year.
COPT Defense Properties Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st were issued a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date of this dividend was Wednesday, December 31st. COPT Defense Properties’s payout ratio is currently 91.73%.
Institutional Investors Weigh In On COPT Defense Properties
Large investors have recently added to or reduced their stakes in the company. Financial Consulate Inc. purchased a new position in shares of COPT Defense Properties in the 3rd quarter worth about $39,000. EverSource Wealth Advisors LLC boosted its stake in COPT Defense Properties by 1,176.5% in the second quarter. EverSource Wealth Advisors LLC now owns 1,685 shares of the company’s stock worth $46,000 after buying an additional 1,553 shares in the last quarter. GAMMA Investing LLC grew its position in COPT Defense Properties by 31.2% during the third quarter. GAMMA Investing LLC now owns 1,973 shares of the company’s stock valued at $57,000 after acquiring an additional 469 shares during the last quarter. Optima Capital LLC purchased a new position in shares of COPT Defense Properties during the fourth quarter worth approximately $63,000. Finally, Osaic Holdings Inc. raised its stake in shares of COPT Defense Properties by 59.6% during the second quarter. Osaic Holdings Inc. now owns 3,193 shares of the company’s stock worth $88,000 after acquiring an additional 1,192 shares in the last quarter.
COPT Defense Properties Company Profile
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.